MIF and CD74 - Suitability as Clinical Biomarkers

E-ISSN： 1875-5607|14|14|1125-1131

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.14, Iss.14, 2014-12, pp. : 1125-1131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Macrophage Migration Inhibitory Factor (MIF) and Its Receptors – Interactions and Suitability as Biomarkers)

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-12 ,pp. : 1115-1115

Bentham Science Publishers

Access to resources Recommend Favorite

The Integral Role of CD74 in Antigen Presentation, MIF Signal Transduction, and B Cell Survival and Homeostasis

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-12 ,pp. : 1132-1138

Bentham Science Publishers

Access to resources Recommend Favorite

CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

By Borghese Federica Clanchy Felix IL

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 237-251

Informa Healthcare

Access to resources Recommend Favorite

Impact of biomarkers on clinical trial risk

By Reid Geoffrey Gilbert John Bin Yameen Tarek Abdullah Parker Jayson Lee

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1645-1658

Future Medicine

Access to resources Recommend Favorite

Clinical Utility of Biomarkers in Premature Atherosclerosis

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2521-2533

Bentham Science Publishers

Access to resources Recommend Favorite